HMB-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HMB-001, covering 2025-12-24 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia [Phase 1, Phase 2]